Excerpts

ANOVA showed that this factor, the derived eABR type, was marginally significant F(2, 14) = 3.62; p = 0.05.

Jonckheere–Terpstra trend test showed a trend of MAP and DBP to increase with increasing PWV ( p < 0.05).

The overall three-group comparison was of borderline significance ( p = 0.050), while pairwise comparisons showed higher OSDI scores in both Group 1 and Group 2 than in controls (both p = 0.034) ( Table 1 ).

A negative trend between N100 amplitude and disease duration was also detected (r = −0.468, p = 0.050).

Age showed a trend for significance with PC (OR 1.03, 95% CI 1–1.06, p = 0.05) ( Table 3 ). 4.

Smoking history approached significance at p = 0.05, with an OR of 2.01, indicating that being a current or former smoker could double the risk of neurological signs compared to never smokers.

Although avoidant coping showed a slight trend toward higher scores in the addicted group, this difference was not significant ( p = 0.05, r = −0.28).

Readmission rates showed a borderline significant difference across continence groups ( p = 0.05), whereas complication severity according to Clavien–Dindo classification did not differ significantly.

The presence of headaches was borderline significant with an OR of 0.04 (95% CI: 0.0006, 0.60; p = 0.05). 4.

Within-group analysis showed a borderline significant improvement in the sham group ( p = 0.05) and a trend toward improvement in the real tDCS group ( p = 0.06).

Results showed a higher survival rate for patients without vocal cord palsy, while those without IONM and with palsy had the worst survival rate, which approached marginal significance ( p = 0.05–0.1). 3.4.

Notably, there was a trend towards a higher rate of chorioamnionitis in the ADHD group that did not reach statistical significance ( p = 0.05).

In the univariate analyses, the degree of DFA stenosis was a significant predictor for major amputation ( p = 0.04) and a borderline significant predictor of improvement of the ankle brachial index ( p = 0.05).

ADC presented a borderline significant discriminatory power (AUC 0.600, p = 0.05), with a significantly lower AUC compared with the SUVavg and short-axis diameter ( p < 0.01 and p = 0.03, n = 162). 3.5.

Influences on vTUG Total Time Among the tested variables, the UPDRS III gait subscore, patient-reported motion status, shoe type, and chair used significantly improved the AIC, reducing it from 998.19 in the base model to 938.57 in the full model, and were highly significant in the likelihood ratio test (LRT) ( p < 0.05).

Additionally, women had a better OS than men, with borderline significance ( p = 0.05).

A borderline significant difference for elevated arterial hypertension rates was seen in BAC-positive patients (35% vs. 27%, p = 0.05).

Survival Pre-HSCT weight, BMI, fat mass, RAPA-Aerobic activity score, Positive Affect, GCGQ score, and ASAS-Wellness all correlated with longer survival; however, these were nominally significant ( p < 0.05) and did not reach significance at our pre-determined level ( p < 0.01).

However, this was of borderline significance p = 0.05.

The means of each group of variables were compared using one-factor ANOVA, with p -values less than 0.01 ( p < 0.01) being considered highly significant and those less than 0.05 ( p < 0.05) being considered significant.

The test for subgroup differences approached significance ( p interaction = 0.05, Cochran’s Q test: p = 0.05; I 2 = 67.7%), suggesting a potential age-dependent efficacy of DOACs compared to aspirin in preventing any recurrent stroke after an ESUS.

The primary endpoint, a reduction in DGF from 26.5 to 20.8%, was only borderline significant ( p = 0.05) when one-sided statistical tests were used in the analysis.

38), pre-SLS test-dominant (26.8% decrease in falls for 1 unit increase in pre-SLS test-dominant, p = 0.003), pre-SLS test-non-dominant (15.9% decrease in falls with 1 unit increase in pre-SLS test-non-dominant, p = 0.029), MMSE (10.9% decrease in falls with 1 unit increase in MMSE, p = 0.018), and marginally significant for pre-FRT (4.6% decrease in falls with 1 unit increase in pre-FRT, p = 0.050).

The test for subgroup differences was borderline significant ( p = 0.05), suggesting that treatment effects may vary according to disease severity ( Figure S9 ).

Cervical metastasis showed a trend toward better outcomes than thoracic or multilevel metastases (OR = 0.26, 95% CI 0.07–1.07, p = 0.05), although this was not significant in the multivariate analysis. 4.